Skip to content
healthcare.dev

SILVER SULFADIAZINE

NDC 59762-0131, silver sulfadiazine, cream, from Mylan Pharmaceuticals Inc..

Product NDC
59762-0131
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA017381
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59762-0131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILVER SULFADIAZINE10 mg/g

Pharmacologic classes

Sulfonamide Antibacterial [EPC]; Sulfonamides [CS]

Package NDCNDC-11Package
59762-0131-0597620131001 TUBE in 1 CARTON (59762-0131-0) / 20 g in 1 TUBE
59762-0131-2597620131021 TUBE in 1 CARTON (59762-0131-2) / 25 g in 1 TUBE
59762-0131-459762013104400 g in 1 JAR (59762-0131-4)
59762-0131-5597620131051 TUBE in 1 CARTON (59762-0131-5) / 50 g in 1 TUBE
59762-0131-65976201310650 g in 1 JAR (59762-0131-6)
59762-0131-8597620131081 TUBE in 1 CARTON (59762-0131-8) / 85 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7a6a9590-9983-46ff-ae5c-fe95f4e16cb8
  • NADAC price for package 59762013100

    GET /v1/drugs/nadac/59762013100
  • NADAC price for package 59762013102

    GET /v1/drugs/nadac/59762013102
  • NADAC price for package 59762013104

    GET /v1/drugs/nadac/59762013104
  • NADAC price for package 59762013105

    GET /v1/drugs/nadac/59762013105
  • NADAC price for package 59762013106

    GET /v1/drugs/nadac/59762013106
  • NADAC price for package 59762013108

    GET /v1/drugs/nadac/59762013108

Use it

Look up 59762-0131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59762-0131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59762-0131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.